CG ONCOLOGY ONCOLYTIC IMMUNOTHERAPY Logo (EUIPO, 12/19/2024)
EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark CG ONCOLOGY ONCOLYTIC IMMUNOTHERAPY was filed as Figurative mark on 12/19/2024 at the European Union Intellectual Property Office. The current status of the mark is "Application published".
Logodesign (Wiener Klassifikation)
#One line or one band #Thin lines #Vertical lines or bands #Monograms formed of intertwined, overlapping or otherwise combined letters #Letter 'C' #Letter 'G' #Gold
| Trademark form | Figurative mark |
| File reference | 019122578 |
| Application date | December 19, 2024 |
| Publication date | February 12, 2025 |
Trademark owner
400 Spectrum Center Dr., Suite 2040
92618 Irvine, CA
US
92618 Irvine, CA
US
Trademark representatives
Laapersveld 75
1213 VB Hilversum
NL
goods and services
5
Pharmaceutical products for the treatment of cancer; pharmaceutical preparations and biological preparations for the treatment of cancer and immunological disorders; Biopharmaceuticals for the treatment of cancer, namely, antibodies, non-antibody proteins, blood and blood components, stem cells, hormones, blood factors, tumor necrosis factors; Chemical preparations for medical or pharmaceutical purposes, namely, for cancer treatment, oncology and immunotherapy for auto immune diseases; Pharmaceutical products, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing
42
Pharmaceutical research and development; Providing medical and scientific research information in the fields of oncology, autoimmune disorders, immunotherapy, immunotherapeutics, biotechnology, biopharmaceuticals, pharmaceuticals, therapies, diseases, and disorders
ID: 11019122578